Brief: Rhythm Biosciences Withdraws Current Colostat Application
05/03/2023 23:15
March 6 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* DECIDED TO WITHDRAW ITS CURRENT COLOSTAT APPLICATION FOR
AN
AUSTRALIAN REGISTER OF THERAPEUTIC GOODS LISTING
* INTENDS TO SUBMIT A NEW COLOSTAT APPLICATION WITH TGA, TO
BETTER
MEET FEEDBACK & QUESTIONS POSED
* THE NEW APPLICATION IS EXPECTED TO BE SUBMITTED IN CURRENT
CALENDAR YEAR
Source text for Eikon: ID:nASX56FMw4
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt